Almirall Throws Down Gauntlet To Dupixent With New Lebrikizumab Data

Positive Results Ahead Of Imminent Filing

 
• By Kevin Grogan
  
Almirall
• Source: Almirall
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D